| Inhibition of antigen processing by the internal repeat region of the Epstein-Barr Virus nuclear antigen-1 J Levitskaya, M Coram, V Levitsky, S Imreh, M Stegerwald-Mullen, G Klein, ... Nature 375, 685-688, 1995 | 1058 | 1995 |
| Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumors N Issaeva, P Bozko, M Enge, M Protopopova, LGGC Verhoef, M Masucci, ... Nature medicine 10 (12), 1321-1328, 2004 | 987 | 2004 |
| Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein–Barr virus nuclear antigen 1 J Levitskaya, A Sharipo, A Leonchiks, A Ciechanover, MG Masucci Proceedings of the National Academy of Sciences 94 (23), 12616-12621, 1997 | 749 | 1997 |
| Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells NP Dantuma, K Lindsten, R Glas, M Jellne, MG Masucci Nature biotechnology 18 (5), 538-543, 2000 | 715 | 2000 |
| Interleukin 10 pretreatment protects target cells from tumor-and allo-specific cytotoxic T cells and downregulates HLA class I expression. M Matsuda, F Salazar, M Petersson, G Masucci, J Hansson, P Pisa, ... The Journal of experimental medicine 180 (6), 2371-2376, 1994 | 421 | 1994 |
| Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific … A Gustafsson, V Levitsky, JZ Zou, T Frisan, T Dalianis, P Ljungman, ... Blood, The Journal of the American Society of Hematology 95 (3), 807-814, 2000 | 399 | 2000 |
| Aggregate formation inhibits proteasomal degradation of polyglutamine proteins LGGC Verhoef, K Lindsten, MG Masucci, NP Dantuma Human molecular genetics 11 (22), 2689-2700, 2002 | 371 | 2002 |
| HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population PO de Campos-Lima, R Gavioli, QJ Zhang, LE Wallace, R Dolcetti, ... Science 260 (5104), 98-100, 1993 | 310 | 1993 |
| The Epstein–Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species B Gruhne, R Sompallae, D Marescotti, SA Kamranvar, S Gastaldello, ... Proceedings of the National Academy of Sciences 106 (7), 2313-2318, 2009 | 297 | 2009 |
| A transgenic mouse model of the ubiquitin/proteasome system K Lindsten, V Menéndez-Benito, MG Masucci, NP Dantuma Nature biotechnology 21 (8), 897-902, 2003 | 273 | 2003 |
| Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation K Lindsten, FMS de Vrij, LGGC Verhoef, DF Fischer, FW van Leeuwen, ... The Journal of cell biology 157 (3), 417-427, 2002 | 267 | 2002 |
| Endoplasmic reticulum stress compromises the ubiquitin–proteasome system V Menendez-Benito, LGGC Verhoef, MG Masucci, NP Dantuma Human molecular genetics 14 (19), 2787-2799, 2005 | 264 | 2005 |
| Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells H Ovaa, BM Kessler, U Rolén, PJ Galardy, HL Ploegh, MG Masucci Proceedings of the National Academy of Sciences 101 (8), 2253-2258, 2004 | 228 | 2004 |
| Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue G Niedobitek, H Herbst, LS Young, L Brooks, MG Masucci, J Crocker, ... Blood 79 (10), 2520-2526, 1992 | 219 | 1992 |
| Three Epstein–Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints B Gruhne, R Sompallae, MG Masucci Oncogene 28 (45), 3997-4008, 2009 | 197 | 2009 |
| Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4 R Gavioli, MG Kurilla, PO de Campos-Lima, LE Wallace, R Dolcetti, ... Journal of virology 67 (3), 1572-1578, 1993 | 196 | 1993 |
| T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of … PO de Campos-Lima, V Levitsky, J Brooks, SP Lee, LF Hu, AB Rickinson, ... Journal of Experimental Medicine 179 (4), 1297-1305, 1994 | 188 | 1994 |
| Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine JY Liu, Y Wu, XS Zhang, JL Yang, HL Li, YQ Mao, Y Wang, X Cheng, ... Cancer Immunology, Immunotherapy 56, 1597-1604, 2007 | 182 | 2007 |
| The Epstein‐Barr virus latent membrane protein‐1 (LMP1) induces interleukin‐10 production in Burkitt lymphoma lines H Nakagomi, R Dolcetti, MT Bejarano, P Pisa, R Kiessling, MG Masucci International journal of cancer 57 (2), 240-244, 1994 | 181 | 1994 |
| Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. MG Masucci, S Torsteindottir, J Colombani, C Brautbar, E Klein, G Klein Proceedings of the National Academy of Sciences 84 (13), 4567-4571, 1987 | 179 | 1987 |
Teresa FrisanDepartment Molecular Biology, Umeå UniveristyE-mail confirmado em umu.se
